Dr Matthew Inada-Kim
MBBS, FRCP
Consultant Acute Physician
National Clinical Director- Infection, Antimicrobial Resistance & Deterioration
National Clinical Lead COVID Oximetry@home/virtual wards
National Specialty Advisor Sepsis
Clinical Director- Digital Innovation
Profile page(s)
Matt is an Acute physician at Hampshire Hospitals, visiting professor at the University of Southampton and Clinical Director for Digital Innovation at Wessex AHSN.
His roles NHS England are as National Clinical Director for Infection management/Sepsis, AMR and Deterioration; for COVID oximetry@home/virtual wards and Lead for the Deterioration and Sepsis CQUINs and is now leading on acute respiratory infections.
He researched/developed/led on national COVID clinical pathways in all settings/policy/evidence in all settings including setting oxygen thresholds for admission/discharge in all hospitals, disseminating the home monitoring strategy across 18 countries during the pandemic.
He is a recognised international expert in sepsis, deterioration, integrated and virtual care and developed multiple webinars with the WHO, RCP, RCPCH, RCEM, BSAC and BGS. He has given invited lectures and discussions across the world on healthcare policy, systems thinking, healthcare innovations and quality improvement strategies globally.
Landmark publications:
2022 Knight, M.J., Subbe, C.P. and Inada-Kim, M. (2022), Racial discrepancies in oximetry: where do we stand?. Anaesthesia, 77: 129-131. https://doi.org/10.1111/anae.15635
2022 Euden J, Thomas-Jones E, Aston S, Inada-Kim M,et al
PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial
BMJ Open 2022;12:e063424. doi: 10.1136/bmjopen-2022-063424
2021 Goyal D, Inada-Kim M, Mansab F, et al. Improving the early identification of COVID-19 pneumonia: a narrative review. BMJ Open Resp Res 2021;8:e000911. doi:10.1136/ bmjresp-2021-000911
2021 Greenhalgh T, Knight M, Inada-Kim M, Fulop N J, Leach J, Vindrola-Padros C et al. Remote management of covid-19 using home pulse oximetry and virtual ward support BMJ 2021; 372 :n677 doi:10.1136/bmj.n677
2021 Inada-Kim; Empowering patients with COVID oximetry, Health Service Journal https://www.hsj.co.uk/service-design/empowering-patients-with-covid-oximetry/7029207.article
2020 Tidswell R, Inada-Kim M, Singer M. Sepsis: the importance of an accurate final diagnosis. Lancet Respir Med. 2021 Jan;9(1):17-18. doi: 10.1016/S2213-2600(20)30520-8. Epub 2020 Nov 2. PMID: 33152272.
2020 Pullyblank A, Tavaré A, Little H, Redfern E, le Roux H, Inada-Kim M ; West of England Patient Safety Collaborative. Implementation of the National Early Warning Score in patients with suspicion of sepsis: evaluation of a system-wide quality improvement project. Br J Gen Pract. 2020 May 28;70(695):e381-e388. doi: 10.3399/bjgp20X709349. PMID: 32269043; PMCID: PMC7147668.
2020 Inada-Kim, Knight, Sullivan, Ainsworth-Smith, Pike, Richardson, Hayward and Lasserson
BJGP Open 12 May 2020; bjgpopen20X101071. DOI: https://doi.org/10.3399/bjgpopen20X101071 The prognostic value of national early warning scores (NEWS) during transfer of care from community settings to hospital: a retrospective service evaluation;
https://bjgpopen.org/content/bjgpoa/early/2020/05/12/bjgpopen20X101071.full.pdf
2019 Singer, Inada-Kim, Shankar-Hari; Sepsis hysteria: excess hype and unrealistic expectations, The Lancet, Volume 394, Issue 10208, 2019, Pages 1513-1514,
https://doi.org/10.1016/S0140-6736(19)32483-3
2018 Redfern; Smith, Gary B; Prytherch; Meredith, Paul; Inada-Kim, Matthew; Schmidt, Paul E. A Comparison of the Quick Sequential (Sepsis-Related) Organ Failure Assessment Score and the National Early Warning Score in Non-ICU Patients With/Without Infection. Critical Care Medicine: December 2018 - Volume 46 - Issue 12 - p 1923-1933 doi: 10.1097/CCM.0000000000003359
2018 Inada-Kim M, Nsutebu E. NEWS 2: an opportunity to standardise the management of deterioration and sepsis BMJ 2018; 360 :k1260
https://www.bmj.com/content/360/bmj.k1260
2018 Mansbridge C, Inada-Kim M. Pneumomediastinum associated with influenza A
New England Journal of Medicine; Jan 2018; vol. 378(no.1)
2017 Inada-Kim M, Page B, Maqsood I, Vincent C. Defining and measuring suspicion of sepsis: an analysis of routine data BMJ Open 2017;7:e014885. doi: 10.1136/bmjopen-2016-014885
https://bmjopen.bmj.com/content/bmjopen/7/6/e014885.full.pdf
Major grants:
2019- NIHR Co Investigator PRONTO
(PROcalcitonin and NEWS evaluation for Timely identification of sepsis and Optimal use of antibiotics in the Emergency Department)
This study aims to reduce ‘just in case’ prescribing and determine which emergency admissions require do or do not require antibiotics.
2011-14 NIHR Investigator: Clinical handover within the emergency care pathway and the potential risks of clinical handover failure (ECHO): Primary research
This was a multisite study to describe the risks and possible solutions to improve communication across healthcare and led to multiple peer reviewed publications, book chapters and an NIHR report.
https://warwick.ac.uk/fac/sci/med/staff/sujan/research/echo/
Impact example:
Led on the research and national guidance on usage of pulse oximeters to monitor patients with COVID at home. This lead to the purchase of 1.2 million oximeters and several national and international programmes, including collaboration with WHO to amend international guidance.
The rapid research was carried out with UoS, SCAS and HHFT colleagues.
Clinical lead of the national virtual wards programme, which has just received £450 million funding.
Now clinical lead for Acute respiratory infections (including pandemic viruses) strategies at NHSE for winter planning and strategy.
National clinical lead for deterioration, and have published widely on scoring systems in all settings, and was a key lead at NHSE and RCP for the development and implementation of NEWS2 across all hospitals and ambulances in England.
Over the last 3 years I have clinically led on and co-authored over 20 national policy documents and clinical pathways; and sit on national leadership groups for all settings (hospitals, Eds and general practice), digital innovation, diagnostic testing, infection management and deterioration.